Verona Pharma Plc Stock Analysis

Verona Stock Analysis Notes

About 95.0% of the company outstanding shares are owned by institutional investors. The company recorded a loss per share of 1.04. Verona Pharma PLC had not issued any dividends in recent years. Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. Verona Pharma plc was incorporated in 2005 and is headquartered in London, the United Kingdom. Verona Pharma is traded on NASDAQ Exchange in the United States. For more information please call David PharmD at 44 20 3283 4200 or visit https://www.veronapharma.com.

Verona Pharma PLC Investment Alerts

Verona Pharma PLC Upcoming and Recent Events

Verona Largest EPS Surprises

View All Earnings Estimates

Verona Pharma Environmental, Social, and Governance (ESG) Scores

Verona Stock Institutional Investors

Note, although Verona Pharma's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Verona Market Capitalization

The company currently falls under 'Mid-Cap' category with a current market capitalization of 9.04 B.

Verona Profitablity

The company has Profit Margin (PM) of (0.37) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of 0.13 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.13.

Management Efficiency

Verona Pharma PLC has return on total asset (ROA) of (0.0668) % which means that it has lost $0.0668 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.3636) %, meaning that it created substantial loss on money invested by shareholders. Verona Pharma's management efficiency ratios could be used to measure how well Verona Pharma manages its routine affairs as well as how well it operates its assets and liabilities. As of September 17, 2025, Return On Tangible Assets is expected to decline to -0.38. In addition to that, Return On Capital Employed is expected to decline to -0.38. At present, Verona Pharma's Total Assets are projected to increase significantly based on the last few years of reporting. The current year's Non Current Assets Total is expected to grow to about 21.7 M, whereas Non Currrent Assets Other are forecasted to decline to about 1.5 M.

Technical Drivers

As of the 17th of September 2025, Verona Pharma has the Risk Adjusted Performance of 0.0684, semi deviation of 0.8419, and Coefficient Of Variation of 1133.76. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Verona Pharma PLC, as well as the relationship between them.

Verona Pharma PLC Price Movement Analysis

Verona Pharma PLC Insider Trading Activities

Verona Pharma Outstanding Bonds

Verona Pharma Predictive Daily Indicators

Verona Pharma Corporate Filings

Verona Pharma Forecast Models

Verona Pharma's time-series forecasting models are one of many Verona Pharma's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Verona Pharma's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Verona Pharma prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Verona shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Verona Pharma. By using and applying Verona Stock analysis, traders can create a robust methodology for identifying Verona entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Verona analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Verona analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Verona Pharma PLC stock analysis indicators help investors evaluate how Verona Pharma stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Verona Pharma shares will generate the highest return on investment. By understating and applying Verona Pharma stock analysis, traders can identify Verona Pharma position entry and exit signals to maximize returns.

When running Verona Pharma's price analysis, check to measure Verona Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Verona Pharma is operating at the current time. Most of Verona Pharma's value examination focuses on studying past and present price action to predict the probability of Verona Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Verona Pharma's price. Additionally, you may evaluate how the addition of Verona Pharma to your portfolios can decrease your overall portfolio volatility.